| Drug Name: | Lurasidone (367514-87-2) |
|---|---|
| PubChem ID: | 57404064 |
| SMILES: | C1CCC([C@@H](C1)CN2C(=O)C3C4CCC(C4)C3C2=O)CN5CCN(CC5)C6=NSC7=CC=CC=C76 |
| InchiKey: | PQXKDMSYBGKCJA-VUOOAKIGSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 492.689 |
| LogP | : | 4.2558 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 6 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 56.75 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|---|---|
| Grapefruit Juice | Orthostatic Hypotension | Grapefruit-medication interactions: forbidden fruit or avoidable consequences? |
| Grapefruit Juice | Syncope | Grapefruit-medication interactions: forbidden fruit or avoidable consequences? |
| Grapefruit Juice | Torsade De Pointes | Grapefruit-medication interactions: forbidden fruit or avoidable consequences? |
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category